Navigation Links
Growth Hormone Won't Fight ALS
Date:11/24/2008

Study shows 'disappointing' results against Lou Gehrig's disease

MONDAY, Nov. 24 (HealthDay News) -- The growth hormone known as insulin-like growth factor-1 (IGF-1) showed no benefit for people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

The two-year U.S. study included 330 patients from 20 medical centers.

Two previous, shorter studies had produced conflicting results. One North American study found that IGF-1 was beneficial, while a European study found no benefit for people with ALS, a progressive, fatal neurodegenerative disease that causes muscles to weaken and deteriorate.

This new study concluded that IGF-1 does not slow progression of muscle weakness.

"It's disappointing that we were not able to confirm the benefit that was found in the North American study. The current treatment options for ALS are inadequate, and more effective treatments are vitally needed," study author Dr. Eric J. Sorenson, of the Mayo Clinic in Rochester, Minn., said in an American Academy of Neurology news release.

Half the patients in the new study were given injections of IGF-1 while the other half received a placebo. The patients' muscle strength was tested at the start of the study and again five times during the two-year study period. Sorenson and his colleagues also tracked how long patients went without needing a tracheostomy (a tube inserted in the neck to assist breathing) and their scores on ongoing tests of their ability to perform daily activities.

The study found no differences between the two groups in muscle strength, how long they went without needing a tracheostomy, or in their ability to perform daily activities.

The findings were published in the Nov. 25 issue of the journal Neurology.

More information

The Muscular Dystrophy Association has more about ALS.



-- Robert Preidt



SOURCE: American Academy of Neurology, news release, Nov. 24, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sermes CRO Deploys Oracle(R) Clinical Applications to Support Growth
2. Frutarom Continues to Implement its Rapid Growth Strategy
3. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
4. Growth Hormone Boost May Not Slow Alzheimers
5. In a Down Economy, Womens Health Company Announces Growth
6. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
7. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
8. The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance
9. Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells
10. Signaling between protein, growth factor is critical for coordinated cell migration
11. NHPCO Reports Growth in Number of Hospice Patients Served, 1.4 Million, With a Wider Range of Illnesses Seen by Providers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Growth Hormone Won't Fight ALS
(Date:5/29/2016)... , ... May 29, 2016 , ... Whole Health Supply ... clipper that has been available via Amazon.com. This new style of nail clipper ... , The jaw opening is approximately 4mm and the actual handle is 2.5mm thick ...
(Date:5/28/2016)... ... May 28, 2016 , ... May 26, 2016- In search ... Fighting Challenge with theme event of “K Warriors” on June 4, 2016 at Ashbury ... , The event is sponsored and hosted by Shaolin Institute and sanctioned by KSF ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and ... the industry, from leading advocates, associations and industry leaders such as Bioness. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... students studying complementary medicine. Allison Outerbridge is this year’s Life University ... May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
Breaking Medicine Technology: